Alternative names, keywords |
N-terminal pro B-type natriuretic peptide, BNP |
||||||||||||||||||||||||
Samples required |
● Clotted blood (gold cap, 5 mL tube). |
||||||||||||||||||||||||
Test indications |
|||||||||||||||||||||||||
Factors affecting test performance/ results |
In rare cases, interference due to extremely high titres of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur. In extremely rare cases (global incidence: < 1 in 10 million), patients may show discrepant results when tested with the assay kit (values below lower detection limit) due to a NT-proBNP genetic variant. Results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings. |
||||||||||||||||||||||||
Reference range |
Reference ranges (see below for clinical cut-offs):
Source: Roche Cobas® Roche Cobas® Elecsys proBNP II kit insert 2023-12, V4.0 Non-HF causes of high NTproBNP: LVH, ischaemia, tachycardia, RV overload, hypoxaemia (including pulmonary embolism), renal dysfunction (GFR < 60 ml/min), sepsis, COPD, diabetes, age > 70 years, cirrhosis of the liver. Clinical cut-offs Please follow local guidance and pathways. From NICE guideline NG106 Chronic heart failure in adults: diagnosis and management (published September 2018, updated September 2025), for patients with suspected heart failure:
Acute heart failure is unlikely if NT-proBNP is less than 300 pg/mL (NICE CG187 Acute heart failure: diagnosis and management (published October 2014, last updated November 2021). Refer to local pathways. |
||||||||||||||||||||||||
Turnaround time |
RSCH same day, PRH within 24h. |
||||||||||||||||||||||||
Enquiries |
Biochemistry (Automation) |